Company intelligence / Profile preview

IPF Fund II

Luxembourg, Luxembourg

Ownership: Private
Development stage: Other

Overview

IPF Fund II is a Luxembourg-domiciled private healthcare growth debt fund managed by IPF Partners. The fund focuses on financing companies in healthcare sectors such as biopharma, medtech, digital health, diagnostics, and healthcare services, with particular emphasis on commercial-stage healthcare companies and late-development-stage biotech businesses. It is not an operating drug-development company and does not itself maintain a therapeutic pipeline, but instead provides structured debt capital to support portfolio companies. IPF Partners announced the fund's final close in November 2020 at approximately EUR 187.5 million.

Industry: Investors

Beyond the preview

Go deeper on IPF Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPF Fund II.

Explore the full profile